<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7033156/table_1" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 1</label>
  <p>Baseline characteristics of patients undergoing chemotherapy for hematological malignancies.</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">col0</th>
   <th colspan="1" rowspan="1" id="0-1-.">col1</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>
    <b>Male gender</b>, n(%) 
   </td>
   <td>233 (55.5%)</td>
  </tr>
  <tr>
   <td>
    <b>Race</b>, n(%) 
   </td>
   <td/>
  </tr>
  <tr>
   <td>Caucasian</td>
   <td>398 (94.8%)</td>
  </tr>
  <tr>
   <td>Asian</td>
   <td>10 (2.4%)</td>
  </tr>
  <tr>
   <td>Hispanic</td>
   <td>8 (1.9%)</td>
  </tr>
  <tr>
   <td>African</td>
   <td>4 (1%)</td>
  </tr>
  <tr>
   <td>
    <b>Age</b>, mean ± SD 
   </td>
   <td>63 ± 16</td>
  </tr>
  <tr>
   <td>
    <b>Most common hematological malignancy</b>, n(%) 
   </td>
   <td/>
  </tr>
  <tr>
   <td>Diffuse large B cell lymphoma</td>
   <td>72 (17.1%)</td>
  </tr>
  <tr>
   <td>Multiple mieloma</td>
   <td>65 (15.5%)</td>
  </tr>
  <tr>
   <td>Follicular lymphoma</td>
   <td>57 (13.6%)</td>
  </tr>
  <tr>
   <td>Acute leukemia</td>
   <td>41 (9.8%)</td>
  </tr>
  <tr>
   <td>Chronic myeloid leukemia</td>
   <td>37 (8.8%)</td>
  </tr>
  <tr>
   <td>Hodgkin lymphoma</td>
   <td>22 (5.2%)</td>
  </tr>
  <tr>
   <td>Myelodysplastic syndrome</td>
   <td>22 (5.2%)</td>
  </tr>
  <tr>
   <td>Chronic lymphocytic leukemia</td>
   <td>18 (4.3%)</td>
  </tr>
  <tr>
   <td>
    <b>Anti-CD20-containing regimens</b>, n(%) 
   </td>
   <td>166 (39.5%)</td>
  </tr>
  <tr>
   <td>
    <b>Tyrosine-kinase inhibitors</b>, n(%) 
   </td>
   <td>64 (15.2%)</td>
  </tr>
  <tr>
   <td>
    <b>HIV infection</b>, n(%) 
   </td>
   <td>4 (1%)</td>
  </tr>
  <tr>
   <td>
    <b>Previously known viral hepatitis</b>, n(%) 
   </td>
   <td>18 (4.3%)*</td>
  </tr>
  <tr>
   <td>Anti-HCV positive</td>
   <td>10</td>
  </tr>
  <tr>
   <td>HBsAg positive</td>
   <td>1</td>
  </tr>
  <tr>
   <td>Anti-HBc positive</td>
   <td>11</td>
  </tr>
 </tbody>
 <tfoot>
  <p>*4 patients were both anti-HCV and anti-HBc positive.</p>
  <p>There were no missing data for any of the variables.</p>
 </tfoot>
</table>
